Trial Profile
A prospective, double blind, randomized, single center study of ivabradine verses metoprolol patients with acute inferior wall myocardial infarction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Oct 2016
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; Metoprolol (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 07 Oct 2016 New trial record